,outcome,arm 1,arm 2
0,intervention,,central evaluations
0,HER2 overexpression/amplification,NR,17.9 % ( 41/229 )
0,"HER2 overexpression/amplification, total study group",37.3 % ( 91/244 ),37.3 % ( 91/244 )
